cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Cormedix Inc
8 own
20 watching
Current Price
$5.14
$0.02
(0.39%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
220.07M
52-Week High
52-Week High
8.025
52-Week Low
52-Week Low
2.645
Average Volume
Average Volume
0.44M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization220.07M
icon52-Week High8.025
icon52-Week Low2.645
iconAverage Volume0.44M
iconDividend Yield--
iconP/E Ratio--
What does the Cormedix Inc do?
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Read More
How much money does Cormedix Inc make?
News & Events about Cormedix Inc.
Globe Newswire
1month ago
BERKELEY HEIGHTS, N.J., May 01, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced that the United States ...
Benzinga
2 months ago
Latest Ratings for CRMD DateFirmActionFromTo May 2021NeedhamMaintainsBuy Feb 2021NeedhamInitiates Coverage OnBuy Feb 2021Truist SecuritiesMaintainsBuy View More Analyst Ratings for CRMD View the Latest Analyst Ratings read more...
Globe Newswire
2 months ago
BERKELEY HEIGHTS, N.J., March 21, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced that it will report its ...
Zolmax
3 months ago
Needham Company LLC reissued their buy rating on shares of CorMedix (NASDAQ:CRMD Get Rating) in a research report report published on Friday morning, Benzinga reports. Needham Company LLC currently has a $13.00 price target on the stock. Separately, JMP Securities lifted their ...
Globe Newswire
4 months ago
BERKELEY HEIGHTS, N.J., Jan. 17, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced the following promotions ...
Frequently Asked Questions
Frequently Asked Questions
What is Cormedix Inc share price today?
plus_minus_icon
Can Indians buy Cormedix Inc shares?
plus_minus_icon
How can I buy Cormedix Inc shares from India?
plus_minus_icon
Can Fractional shares of Cormedix Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Cormedix Inc stocks?
plus_minus_icon
What is today’s traded volume of Cormedix Inc?
plus_minus_icon
What is today’s market capitalisation of Cormedix Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Cormedix Inc?
plus_minus_icon
What percentage is Cormedix Inc down from its 52-Week High?
plus_minus_icon
What percentage is Cormedix Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$5.14
$0.02
(0.39%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00